venBio Global Strategic Fund II L.P. Insider Trading $AKRO Akero Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for venBio Global Strategic Fund II L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of venBio Global Strategic Fund II L.P.. venBio Global Strategic Fund II L.P. is in IMPEL NEUROPHARMA INC ($IMPL) and 10% Owner in Apellis Pharmaceuticals, Inc. ($APLS) and 10% Owner in Menlo Therapeutics, Inc. ($MNLO) and in Checkmate Pharmaceuticals, Inc. ($CMPI) and in Akero Therapeutics, Inc. ($AKRO) and 10% Owner in Akero Therapeutics, Inc. ($AKRO).
venBio Global Strategic Fund II L.P. in Akero Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of venBio Global Strategic Fund II L.P.:
Holdings: 3,041,955 shares
Latest Transaction: Jul 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of venBio Global Strategic Fund II L.P. in Akero Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRO, APLS, CMPI, IMPL, MNLO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | Sell | S | 33.83 | 4,603 | 155,721 | 3,033,552 | 3 M to 3 M (-0.15 %) | |
| Jul 06 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | Sell | S | 33.63 | 3,800 | 127,805 | 3,038,155 | 3 M to 3 M (-0.12 %) | |
| Jul 06 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | Sell | S | 34.45 | 108,064 | 3,723,010 | 3,041,955 | 3.2 M to 3 M (-3.43 %) | |
| Mar 06 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 23.79 | 1,800 | 42,831 | 3,150,019 | 3.2 M to 3.2 M (-0.06 %) |
| Mar 06 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 23.53 | 8,500 | 200,011 | 3,151,819 | 3.2 M to 3.2 M (-0.27 %) |
| Mar 06 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 23.81 | 35,650 | 848,766 | 3,160,319 | 3.2 M to 3.2 M (-1.12 %) |
| Mar 03 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 23.00 | 6,401 | 147,199 | 3,195,969 | 3.2 M to 3.2 M (-0.20 %) |
| Mar 03 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 23.06 | 10,297 | 237,459 | 3,202,370 | 3.2 M to 3.2 M (-0.32 %) |
| Mar 03 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 21.30 | 5,100 | 108,652 | 3,212,667 | 3.2 M to 3.2 M (-0.16 %) |
| Feb 27 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 22.54 | 1,781 | 40,144 | 3,227,767 | 3.2 M to 3.2 M (-0.06 %) |
| Feb 27 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 22.44 | 2,523 | 56,615 | 3,229,548 | 3.2 M to 3.2 M (-0.08 %) |
| Feb 27 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 23.67 | 1,600 | 37,876 | 3,232,071 | 3.2 M to 3.2 M (-0.05 %) |
| Feb 12 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 27.14 | 6 | 163 | 3,233,671 | 3.2 M to 3.2 M (0.00 %) |
| Feb 12 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 27.05 | 2,184 | 59,068 | 3,233,677 | 3.2 M to 3.2 M (-0.07 %) |
| Feb 12 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 27.08 | 7,836 | 212,168 | 3,225,861 | 3.2 M to 3.2 M (-0.24 %) |
| Feb 10 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 27.03 | 6,102 | 164,955 | 3,233,697 | 3.2 M to 3.2 M (-0.19 %) |
| Feb 06 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 25.99 | 28,608 | 743,548 | 3,239,799 | 3.3 M to 3.2 M (-0.88 %) |
| Feb 06 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 25.65 | 53,731 | 1,378,179 | 3,268,407 | 3.3 M to 3.3 M (-1.62 %) |
| Jan 14 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 20.23 | 494,000 | 9,993,620 | 3,322,138 | 3.8 M to 3.3 M (-12.95 %) |
| Jan 10 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 19.86 | 15,677 | 311,355 | 3,816,138 | 3.8 M to 3.8 M (-0.41 %) |
| Jan 08 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 20.17 | 31,000 | 625,149 | 3,831,815 | 3.9 M to 3.8 M (-0.80 %) |
| Jan 08 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 19.64 | 42,221 | 829,381 | 3,862,815 | 3.9 M to 3.9 M (-1.08 %) |
| Jan 06 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 19.30 | 12,498 | 241,214 | 3,905,036 | 3.9 M to 3.9 M (-0.32 %) |
| Jan 06 2020 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Sell | S | 19.94 | 23,000 | 458,507 | 3,917,534 | 3.9 M to 3.9 M (-0.58 %) |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Option Exercise | C | 0.00 | 722,737 | 0 | 0 | |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Option Exercise | C | 0.00 | 10,666,667 | 0 | 0 | |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Buy | C | 0.00 | 235,099 | 0 | 3,954,858 | 3.7 M to 4 M (+6.32 %) |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Buy | C | 0.00 | 3,469,759 | 0 | 3,719,759 | 250 K to 3.7 M (+1,387.90 %) |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | venBio Global Strategic Fund I ... | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 250,000 | 0 to 250 K |
Page: 1